Firmagon Uniunea Europeană - română - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostate neoplasme - terapia endocrină - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Visudyne Uniunea Europeană - română - EMA (European Medicines Agency)

visudyne

cheplapharm arzneimittel gmbh - verteporfina - myopia, degenerative; macular degeneration - oftalmologice - visudyne este indicat pentru tratamentul:adulți cu exudativa (umeda) degenerescenta maculara legata de varsta (amd), cu precădere clasic neovascularizație coroidiană subfoveală (cnv) sau;adulți cu neovascularizație coroidiană subfoveală secundară unei miopii patologice.